Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Epstein

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Aldosterone receptor blockade and the role of eplerenone: evolving perspectivesMurray Epstein
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 16, 2022
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm ShiftMurray Epstein
Contributions to Nephrology|July 14, 2004
Role of aldosterone blockade in the management of hypertension and cardiovascular diseaseMurray Epstein
Nature Clinical Practice. Nephrology|November 5, 2008
Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney diseaseMurray Epstein
Expert Opinion on Pharmacotherapy|May 17, 2016
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromerMurray Epstein, Bertram Pitt
Current Hypertension Reports|May 11, 2002
The use of calcium antagonists in the treatment of hypertensive persons with kidney diseaseSheldon Tobe, Murray Epstein
Nephrology News & Issues|June 4, 2016
Clinical and electrophysiological consequences of hyperkalemiaMurray Epstein, Markus Ketteler
European Journal of Heart Failure|February 4, 2022
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fractionBertram Pitt, Murray Epstein
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2021
The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injuryMurray Epstein, Michael Freundlich
American Journal of Physiology. Renal Physiology|May 22, 2015
A forgotten chapter in the history of the renal circulation: the Josep Trueta and Homer Smith intellectual conflictMurray Epstein, Garabed Eknoyan
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Aldosterone receptor blockade and the role of eplerenone: evolving perspectivesMurray Epstein
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 16, 2022
A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm ShiftMurray Epstein
Contributions to Nephrology|July 14, 2004
Role of aldosterone blockade in the management of hypertension and cardiovascular diseaseMurray Epstein
Nature Clinical Practice. Nephrology|November 5, 2008
Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney diseaseMurray Epstein
Expert Opinion on Pharmacotherapy|May 17, 2016
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromerMurray Epstein, Bertram Pitt
Current Hypertension Reports|May 11, 2002
The use of calcium antagonists in the treatment of hypertensive persons with kidney diseaseSheldon Tobe, Murray Epstein
Nephrology News & Issues|June 4, 2016
Clinical and electrophysiological consequences of hyperkalemiaMurray Epstein, Markus Ketteler
European Journal of Heart Failure|February 4, 2022
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fractionBertram Pitt, Murray Epstein
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2021
The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injuryMurray Epstein, Michael Freundlich
American Journal of Physiology. Renal Physiology|May 22, 2015
A forgotten chapter in the history of the renal circulation: the Josep Trueta and Homer Smith intellectual conflictMurray Epstein, Garabed Eknoyan
Pageof 8